Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes.
D045930:Anabolic Agents / Q000494:pharmacology; D000818:Animals; D001796:Blood Protein Disorders / Q000201:enzymology / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology*; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006493:Heparin; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008071:Lipoprotein Lipase / Q000378:metabolism; D008074:Lipoproteins / Q000097:blood; D008297:Male; D009640:Norethindrone / Q000627:therapeutic use; D010074:Oxandrolone / Q000627:therapeutic use; D011247:Pregnancy; D011372:Progestins / Q000494:pharmacology; D013256:Steroids / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood*
D045930:Anabolic Agents; D003276:Contraceptives, Oral; D004967:Estrogens; D008055:Lipids; D008074:Lipoproteins; D011372:Progestins; D013256:Steroids; D014280:Triglycerides; D010074:Oxandrolone; D006493:Heparin; D002784:Cholesterol; D008071:Lipoprotein Lipase; D009640:Norethindrone